Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

J&J Tries to Expand Invokana Label to Include Cardiovascular Benefits

October 9, 2017 By Law Offices of Thomas J. Lamb, P.A.


Johnson & Johnson’s, the drug manufacturer of diabetes drugs Invokana, Invokamet, and Invokamet XR, recently submitted a supplemental new drug application (sNDA) to the FDA to request expansion of the labels for these drugs.

If granted, the new label would include a cardiovascular indication concerning the reduction of risk of cardiovascular events in type 2 diabetes patients who have established CV disease or are at risk for CV disease.

The results of several recent studies on Invokana, called CANVAS and CANVAS-R, served as the catalysts for J&J’s request.  These studies showed that patients who used Invokana / Invokamet / Invokamet XR–compared to those taking a placebo–were less likely to experience the following major cardiovascular events (MACE):

  • Cardiovascular death
  • Nonfatal myocardial infarctions (MI) / Heart attacks
  • Strokes

However, these studies also brought to light a serious side effect of Invokana that has recently gained more attention in the medical literature.

In July of this year, the risk of amputations–particularly of the lower limbs–was included in a black box warning on the drug label for Invokana, Invokamet, and Invokamet XR.  Black box warnings are the highest level of required warning for drugs manufactured and sold in the U.S., which illustrates just how severe this potential side effect is.

To read more about this increased warning, see my latest article on the topic, “Could Invokana have been the cause of my lower-limb amputation?”

Going forward, it will be interesting to see whether the cardiovascular benefits of Invokana, Invokamet, and Invokamet XR will make up for any decrease in prescriptions due to the serious amputation side effects of these drugs.

We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for those who have undergone amputations of the lower limbs while using Invokana or other type 2 diabetes drugs.  We encourage you to complete a free case evaluation, and visit our website for more information on these drugs and their potential side effects.

 

Written by: Heather Helmendach, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.


Drug Injury Watch
: Side Effects News & Reports

Drug Injury Law: Medical & Legal Information


Previous articles on this topic:

  • Could Invokana have been the cause of my lower-limb amputation?
  • Can SGLT-2 Inhibitor Diabetes Drugs Increase Your Risk of Stroke?
  • Invokana Shown to Have Heart Benefits, but Elevated Amputation Risks
  • Risk of Lower Limb Amputations Doubled with Invokana and Invokamet Use
  • All SGLT2 Inhibitors Now Investigated for Increased Risk of Amputation
  • Are Invokana & Invokamet Linked to Increased Risk of Toe Amputations?

 

Filed Under: Unsafe Drugs Tagged With: Cardiovascular death, diabetes drugs amputation, diabetes drugs side effects, drug label changes, FDA, foot amputations, Heart Attacks, Invokamet, invokamet xr, Invokana, johnson & johnson's, leg amputations, nonfatal myocardial infarctions, sNDA, supplemental new drug application, toe amputations, type 2 diabetes drugs

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.